Schedule 13D ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 par value · CUSIP: 252828108

Event date: 2025-11-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Avidity Partners Management LPReported CIK 0001791827

    Shares: 2,104,184.00 · Class: 4.9%

  • Avidity Partners Management (GP) LLC

    Shares: 2,104,184.00 · Class: 4.9%

  • Avidity Capital Partners Fund (GP) LP

    Shares: 2,104,184.00 · Class: 4.9%

  • Avidity Capital Partners (GP) LLC

    Shares: 2,104,184.00 · Class: 4.9%

  • Avidity Private Master Fund I LP

    Shares: 1,899,593.00 · Class: 4.4%

  • Michael Gregory

    Shares: 2,104,184.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-007115
Form type
SCHEDULE 13D/A
Filer
Avidity Partners Management LP
CIK
CIK 1791827
Filed
Nov 19, 2025
Reporting period
Nov 17, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub